TY - JOUR
T1 - Written exposure as an intervention for PTSD
T2 - A randomized clinical trial with motor vehicle accident survivors
AU - Sloan, Denise M.
AU - Marx, Brian P.
AU - Bovin, Michelle J.
AU - Feinstein, Brian A.
AU - Gallagher, Matthew W.
N1 - Funding Information:
This study was supported by a National Institute of Mental Health grant ( R34MH077658-02 ) awarded to Denise M. Sloan.
PY - 2012/10
Y1 - 2012/10
N2 - The present study examined the efficacy of a brief, written exposure therapy (WET) for posttraumatic stress disorder (PTSD). Participants were 46 adults with a current primary diagnosis of motor vehicle accident-related PTSD. Participants were randomly assigned to either WET or a waitlist (WL) condition. Independent assessments took place at baseline and 6-, 18-, and 30-weeks post baseline (WL condition not assessed at 30 weeks). Participants assigned to WET showed significant reductions in PTSD symptom severity at 6- and 18-week post-baseline, relative to WL participants, with large between-group effect sizes. In addition, significantly fewer WET participants met diagnostic criteria for PTSD at both the 6- and 18-week post-baseline assessments, relative to WL participants. Treatment gains were maintained for the WET participants at the 30-week post baseline assessment. Notably, only 9% of participants dropped out of WET and the WET participants reported a high degree of satisfaction with the treatment. These findings suggest that a brief, written exposure treatment may efficaciously treat PTSD. Future research should examine whether WET is efficacious with other PTSD samples, as well as compare the efficacy of WET with that of evidence-based treatments for PTSD.
AB - The present study examined the efficacy of a brief, written exposure therapy (WET) for posttraumatic stress disorder (PTSD). Participants were 46 adults with a current primary diagnosis of motor vehicle accident-related PTSD. Participants were randomly assigned to either WET or a waitlist (WL) condition. Independent assessments took place at baseline and 6-, 18-, and 30-weeks post baseline (WL condition not assessed at 30 weeks). Participants assigned to WET showed significant reductions in PTSD symptom severity at 6- and 18-week post-baseline, relative to WL participants, with large between-group effect sizes. In addition, significantly fewer WET participants met diagnostic criteria for PTSD at both the 6- and 18-week post-baseline assessments, relative to WL participants. Treatment gains were maintained for the WET participants at the 30-week post baseline assessment. Notably, only 9% of participants dropped out of WET and the WET participants reported a high degree of satisfaction with the treatment. These findings suggest that a brief, written exposure treatment may efficaciously treat PTSD. Future research should examine whether WET is efficacious with other PTSD samples, as well as compare the efficacy of WET with that of evidence-based treatments for PTSD.
KW - Clinical trial
KW - Exposure treatment
KW - Motor vehicle accident
KW - PTSD
KW - Trauma
UR - http://www.scopus.com/inward/record.url?scp=84865620432&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865620432&partnerID=8YFLogxK
U2 - 10.1016/j.brat.2012.07.001
DO - 10.1016/j.brat.2012.07.001
M3 - Article
C2 - 22863540
AN - SCOPUS:84865620432
SN - 0005-7967
VL - 50
SP - 627
EP - 635
JO - Behaviour Research and Therapy
JF - Behaviour Research and Therapy
IS - 10
ER -